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that the KIM has a finite gating threshold and therefore, in 
the presence of motion, it will deviate from the planned 
treatment. 
 
Figure 1. (a) Planned, (b) delivered with KIM gating, and (c) 
simulated delivery without KIM gating correction isodose 
distributions for a fraction of patient 1. Dose levels >95% are 
shown. 
 
Conclusions: The initial results indicate that KIM gating 
improves the agreement between the planned and delivered 
treatments for prostate radiotherapy. A more accurate 
delivery with KIM can facilitate dose escalation and also 
potentially improve treatment outcomes. Future work will 
include investigation of more patients and fraction data, and 
statistical analysis.  
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Purpose/Objective: Kilovoltage Intrafraction Monitoring 
(KIM) is a new real-time IGRT system undergoing first-in-
world clinical use. With KIM, the kV imager is employed while 
the MV beam is on. Radio-opaque markers implanted into the 
target are detected in the kV images, and 2D-to-3D 
reconstruction is performed to compute the 3D target 
position in real-time. The 3D target position is displayed to 
the clinical team during treatment and is used to make 
guidance decisions. KIM has shown sub-millimetre accuracy 
from phantom experiments and retrospective prostate and 
liver cancer patient studies. However to date there have 
been no prospective patient results where KIM is employed in 
real-time to make guidance decisions. We report the 
accuracy measurements from the first prospective clinical 
trial of KIM for prostate cancer VMAT patients. 
Materials and Methods: Simultaneous intratreatment kV and 
MV images of the 52 fractions from the three prostate cancer 
patients treated with KIM real-time guidance to date were 
acquired. For each treatment fraction the KIM real-time 
measurements of the prostate implanted marker positions 
were compared to retrospectively measured kV-MV 
triangulated marker positions. The kV-MV triangulated 
positions were considered to be the ground truth. The mean 
and standard deviation of the measured position differences 
between KIM and kV-MV triangulation in the left-right (LR), 
superior-inferior (SI) and anterior-posterior (AP) directions 
were recorded and analysed. Due to the VMAT MLC 
modulation, the markers were not visible in all MV images, 
however at least one marker was visible in 6461 (of 47320 
total) images, with the number of images available for 
analysis in any one fraction ranging from 66 to 167. 
Results: The mean error of KIM in the LR, SI and AP directions 
was 0.17, 0.55, and -0.61 mm respectively, with standard 
deviations of 0.56, 0.29 and 0.48 mm respectively. The 
accuracy results for each fraction of each patient are shown 
in the figure. The accuracy and precision are both sub-
millimetre. The results across the fractions and patients are 
quite similar, indicating that further improvements to the 
accuracy could be performed to reduce the residual small 
systematic accuracy error. 
 
 
Conclusions: A new real-time tumour position monitoring 
system, Kilovoltage Intrafraction Monitoring (KIM), has been 
clinically implemented and demonstrated to have sub-
millimetre accuracy and precision in the results to date. As 
KIM is implemented on a standard linear accelerator with 
little modification, this accurate technology can potentially 
be widely used on existing cancer radiotherapy systems.  
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Purpose/Objective: Radiotherapy treatment for breast 
cancer increases the risk of major coronary events1, with 
dose received by the Left Anterior Descending (LAD) coronary 
artery an area of particular concern2. Deep inspiration 
breath-hold (DIBH) is demonstrated as an effective method to 
reduce cardiac doses during breast irradiation3. Following its 
implementation across our centres a reduction of mean heart 
dose was observed for left sided breast radiotherapy. This 
study will further investigate these changes in cardiac dose 
and explore LAD mean and maximum doses. 
Materials and Methods: This retrospective study investigated 
275 left-sided breast cancer patients treated with DIBH 
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across eight centres between January 2014 and November 
2014. All patients underwent two CT scans, one in free 
breathing (FB) and one in DIBH using the Spiro Dynr' X 
breathing control system. Planning was completed on the 
DIBH scan and transferred to FB scans using tissue volume 
equivalence on Phillips Pinnacle3 TPS. An agreed standard 
atlas for whole heart and LAD contouring was followed to 
ensure internal consistency. Treatment techniques included a 
two field tangential approach or a three field technique 
irradiating additional nodal involvement. Dose regimes 
prescribed were either 40Gy/15# or 50Gy/25# and patients 
were treated on Elekta Synergy or Versa HD linear 
accelerators using forward planned intensity modulated 
radiotherapy (IMRT). As per ICRU 83 the Mean dose to the 
whole heart and LAD were recorded along with the Near 
Maximum(2%) LAD dose. Given that the data was not normally 
distributed, statistical significance was validated using the 
Wilcoxon Signed Rank test.  
Results: The mean heart dose observed for DIBH was 1.02Gy 
(95% CI 0.98-1.05), compared with 1.69Gy (95% CI 1.61-1.77) 
for FB. The results indicate that DIBH led to a significant 
decrease in mean heart dose of 0.67Gy (p<0.001). Initial 
results also suggest a reduction in LAD mean and maximum 
doses for patients treated in DIBH (figure 1). Further results 
will be described.  
 
Table 1. Comparison of LAD doses in DIBH vs. FB 
 
 
 
Conclusions: DIBH significantly reduces cardiac doses during 
left breast treatment. This technique has clear potential to 
decrease long-term cardiac complications in women having 
breast radiotherapy.  
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Purpose/Objective: We present a general theoretical 
framework for combining image registration and respiratory 
motion models. We demonstrate this framework applied to a 
software phantom and real dynamic MRI, 4DCT, and Cine CT 
lung data. This framework has a wide range of potential 
applications, both in RT and other fields, including planning 
and guiding therapy delivery, and motion compensating PET, 
SPECT, and functional MR images. 
Materials and Methods: Respiratory motion models relate the 
motion of the internal anatomy, which can be difficult to 
directly measure during therapy delivery or long image 
acquisitions, to easily measured surrogate signals, such as the 
motion of the skin surface or spirometry data. Typically, such 
models are built by first using image registration to 
determine the motion from a number of prior images, and 
then fitting a correspondence model that relates the motion 
to the surrogate signals. Our new framework combines the 
image registration and model fitting into a single 
optimisation problem, directly fitting the correspondence 
model to all of the image data simultaneously. This not only 
leads to a more theoretically efficient and robust approach to 
building the motion models, but also enables the use of 
‘partial’ imaging data such as individual MR and CT slices, or 
CT projection data, where it is not possible to determine the 
full 3D motion from a single image. Our framework can be 
used with a wide range of registration algorithms, including 
different transformation models, similarity measures and 
constraint terms, and a wide range of correspondence 
models, including linear, polynomial, and B-spline models. 
The framework can also be extended to incorporate motion 
compensated image reconstruction by iterating between the 
model fitting and the image reconstruction, removing the 
need for a static reference volume. This means it is possible 
to estimate both the motion and a motion compensated 
reconstruction from just the partial imaging data and the 
surrogate signals.  
Results: We initially implemented our framework using a 
demons-like registration algorithm and demonstrated it using 
synthetic slice and projection data from a simple 2D 
phantom, recovering 69-94% of the motion and giving high 
quality reconstructions. We now implemented the framework 
with the popular B-spline based NiftyReg registration 
software, and have applied it to real MRI, 4DCT, and Cine CT 
lung data, giving very promising results, with the motion 
estimated by the model visually matching the motion seen in 
the real data well. 
Conclusions: We have presented a general framework for 
combining image registration, motion modelling, and motion 
compensated image reconstruction. We have demonstrated 
this on data from a software phantom and real dynamic MRI, 
4DCT, and Cine CT lung data, achieving good results in all 
cases. 
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Purpose/Objective: The gated delivery of radiation is a 
potential technique for reducing the effects of respiratory 
motion and respiratory gated radiotherapy may allow 
reduction of the treatment margins, thus sparing healthy 
tissue and/or allowing dose escalation to the tumor. In the 
